Jens Juul Holst The Work: The independent and collaborative work of Daniel Drucker, Joel Habener and Jens Holst enhanced our understanding of how our gastrointestinal organs function and created new classes of drugs for the treatment of metabolic disorders, specifically type 2 diabetes, obesity and short bowel syndrome
Do I need to provide lab work or prior health info
Please contact the authors if you need specific advice.
These natural GLP1 secretagogues include widely available herbs and foods, offering a gentler, oral approach to support metabolic health without injections
"Unfortunately, price is what is driving the decision-making between clinicians and patients for these drugs because they're all excellent drugs and we have lots of options now, but it's still a financial decision at the end of the day," Kansal said
This pattern is similar to whats been seen with other medications in this class